FPS still looks ahead
21 November 2016 | By F.P.S. Food and Pharma Systems Srl
FPS is pleased to announce the enlargement of his production plant...
List view / Grid view
News
NICE recommends faecal immunochemical tests for colorectal cancer
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
FITs are considered to be accurate because unlike other tests, they use immunochemical detection methods that are specific to human haemoglobin...
Boehringer Ingelheim’s bevacizumab biosimilar demonstrates bioequivalence
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
BI 695502, a bevacizumab biosimilar candidate to Avastin, is a monoclonal antibody that may slow or stop the growth of certain tumour types by preventing...
Sanofi and Regeneron’s rheumatoid arthritis drug shows superior results
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Sanofi and Regeneron presented results of a Phase 3 study demonstrating the superiority of investigational sarilumab monotherapy versus adalimumab...
Price discount helps give green light for Roche’s breast cancer drug
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A discount to the price of pertuzumab agreed with the company was an important factor in enabling NICE to overturn its earlier provisional decision...
UCB and Amgen’s Osteoporosis study shows bone mineral density gains
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The BRIDGE study involved 245 men with osteoporosis randomised 2:1 to receive either 210 mg romosozumab or placebo subcutaneously once monthly for 1 year...
Novartis’ acute myeloid leukaemia drug granted FDA priority review
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The FDA granted priority review to the PKC412 (midostaurin) new drug application as treatment for acute myeloid leukaemia...
Tackling resistance: 3/4 Brits support mandatory test before antibiotic prescriptions
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Around three-quarters (74%) of people believe that a positive test for bacterial infection should be compulsory before being able to access antibiotics...
AbbVie’s Hep C drug achieves high SVR rates after just 8 weeks of treatment
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In more than 700 genotype 1-6 chronic HCV infected patients, 97.5% achieved sustained virologic response at 12 weeks, regardless of baseline viral load...
EC approval for Lilly’s soft tissue sarcoma drug Olaratumab
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
This conditional marketing authorisation is based on data from the Phase 2 portion of the pivotal JGDG trial and followed a positive recommendation from...
FDA approves Bristol-Myers Squibb’s Opdivo as first Immuno-Oncology treatment
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Opdivo is the first and only Immuno-Oncology treatment proven in a Phase 3 trial to significantly extend overall survival for these patients...
Genmab to trial daratumumab in combination with carfilzomib to treat multiple myeloma
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Genmab’s daratumumab (darazalex) will be investigated in a Phase III clinical study in combination with carfilzomib (kyprolis) and dexamethasone...
NICE approves three quarters of CDF drugs for routine NHS use
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
More than 75% of treatments in the Cancer Drugs Fund (CDF) which have been reappraised by the National Institute for Health and Care Excellence (NICE) have received positive recommendations for routine use in the NHS. NICE has been reappraising cancer drugs which had not been recommended in previous NICE guidance…
Linkam launches a new platform to replicate large scale freeze drying systems
Linkam Scientific Instruments, announce the launch of the FDVS platform, a lyophilisation system to replicate large scale freeze drying processes...
LIVE: FT global pharmaceutical and biotechnology conference
15 November 2016 | By Niamh Louise Marriott, Digital Content Producer
We’re live at the Financial Times global pharmaceutical and biotechnology conference! Check this stream for live updates of the event…
